Key Stats

Expense Ratio Total Assets Under Management Dividend Yield Turnover Ratio
0.17% 99.70B 2.44% 5.00%
1 Year Fund Level Flows 1 Year Total Returns (Daily) Annualized All Time Total Returns (Daily) Max Drawdown (All)
8.063B -4.10% Upgrade Upgrade

Basic Info

Investment Strategy
The investment seeks to track the performance of the CRSP US Large Cap Value Index that measures the investment return of large-capitalization value stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
General
Security Type Mutual Fund
Oldest Share Symbol VIVAX
Equity Style Large Cap/Value
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Value
Category Index Russell 1000 Value TR USD
Global Category Name US Equity Large Cap Value
YCharts Categorization US Large Cap Value
YCharts Benchmark Russell 1000 Value Total Return (^RLVTR)
Prospectus Objective Growth
Fund Owner Firm Name Vanguard
Prospectus Benchmark Index
CRSP US Large Cap Value TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Gerard O’Reilly 28.18 yrs
Walter Nejman 6.85 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 1
8.063B
-6.415B Category Low
13.81B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of February 28, 2023

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of March 31, 2023. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
16.75%
16.99%
-5.55%
25.67%
2.18%
26.31%
-2.18%
-1.01%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
7.50%
14.63%
16.22%
-12.64%
23.30%
7.78%
23.74%
-10.57%
1.37%
14.52%
17.59%
-12.07%
27.54%
3.85%
25.25%
-2.66%
-0.60%
16.17%
15.83%
-11.32%
24.98%
-3.66%
28.20%
-4.25%
0.16%
As of March 31, 2023.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (3-31-23) 2.44%
30-Day SEC Yield (3-24-23) Upgrade
7-Day SEC Yield (11-28-03) Upgrade
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 15.89
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of February 28, 2023

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of February 28, 2023

Asset Allocation

As of February 28, 2023.
Type % Net % Long % Short
Cash 0.15% Upgrade Upgrade
Stock 99.85% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Berkshire Hathaway Inc Class B 3.12% 308.77 1.21%
Exxon Mobil Corp 2.67% 109.66 0.16%
UnitedHealth Group Inc 2.62% 472.59 0.54%
JPMorgan Chase & Co 2.48% 130.31 1.21%
Johnson & Johnson 2.36% 155.00 1.02%
Procter & Gamble Co 1.92% 148.69 0.84%
Chevron Corp 1.65% 163.16 0.47%
AbbVie Inc 1.60% 159.37 0.92%
Merck & Co Inc 1.59% 106.39 0.44%
Broadcom Inc 1.42% 641.54 1.23%

Fees & Availability

Fees
Actual 12B-1 Fee --
Actual Management Fee Upgrade
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Purchase Details
Open to New Investors No
Open to Existing Investors Yes
Minimum Initial Investment Upgrade
Minimum Subsequent Investment Upgrade

Basic Info

Investment Strategy
The investment seeks to track the performance of the CRSP US Large Cap Value Index that measures the investment return of large-capitalization value stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
General
Security Type Mutual Fund
Oldest Share Symbol VIVAX
Equity Style Large Cap/Value
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Value
Category Index Russell 1000 Value TR USD
Global Category Name US Equity Large Cap Value
YCharts Categorization US Large Cap Value
YCharts Benchmark Russell 1000 Value Total Return (^RLVTR)
Prospectus Objective Growth
Fund Owner Firm Name Vanguard
Prospectus Benchmark Index
CRSP US Large Cap Value TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Gerard O’Reilly 28.18 yrs
Walter Nejman 6.85 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (3-31-23) 2.44%
30-Day SEC Yield (3-24-23) Upgrade
7-Day SEC Yield (11-28-03) Upgrade
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 15.89
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of February 28, 2023

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of February 28, 2023

Fund Details

Key Dates
Inception Date 11/2/1992
Last Annual Report Date 12/31/2022
Last Prospectus Date 4/29/2022
Share Classes
VIVIX Inst
VVIAX Inst
Attributes
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

Top Portfolio Holders

0 of 0